Masseria C - Search Results

1

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients.

Lip GYH, Keshishian A, Li X, Hamilton M, Masseria C, Gupta K, Luo X, Mardekian J, Friend K, Nadkarni A, Pan X, Baser O, Deitelzweig S. Lip GYH, et al. Among authors: masseria c. Stroke. 2018 Dec;49(12):2933-2944. doi: 10.1161/STROKEAHA.118.020232. Stroke. 2018. PMID: 30571400 Free PMC article.

2

Stroke associated with discontinuation of warfarin therapy for atrial fibrillation.

Spivey CA, Liu X, Qiao Y, Mardekian J, Parker RB, Phatak H, Masseria C, Kachroo S, Abdulsattar Y, Wang J. Spivey CA, et al. Among authors: masseria c. Curr Med Res Opin. 2015 Nov;31(11):2021-9. doi: 10.1185/03007995.2015.1082995. Epub 2015 Sep 21. Curr Med Res Opin. 2015. PMID: 26390258

3

Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United States.

Lip GY, Pan X, Kamble S, Kawabata H, Mardekian J, Masseria C, Bruno A, Phatak H. Lip GY, et al. Among authors: masseria c. Int J Clin Pract. 2016 Sep;70(9):752-63. doi: 10.1111/ijcp.12863. Epub 2016 Aug 23. Int J Clin Pract. 2016. PMID: 27550177 Free PMC article.

4

Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.

Lip GYH, Pan X, Kamble S, Kawabata H, Mardekian J, Masseria C, Phatak H. Lip GYH, et al. Among authors: masseria c. PLoS One. 2018 Apr 30;13(4):e0195950. doi: 10.1371/journal.pone.0195950. eCollection 2018. PLoS One. 2018. PMID: 29709012 Free PMC article.

5

Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.

Lopes RD, Steffel J, Di Fusco M, Keshishian A, Luo X, Li X, Masseria C, Hamilton M, Friend K, Gupta K, Mardekian J, Pan X, Baser O, Jones WS. Lopes RD, et al. Among authors: masseria c. Am J Med. 2018 Sep;131(9):1075-1085.e4. doi: 10.1016/j.amjmed.2018.05.007. Epub 2018 May 26. Am J Med. 2018. PMID: 29807001

6

A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants.

Cohen AT, Hill NR, Luo X, Masseria C, Abariga SA, Ashaye AO. Cohen AT, et al. Among authors: masseria c. Int J Cardiol. 2018 Oct 15;269:174-181. doi: 10.1016/j.ijcard.2018.06.114. Epub 2018 Jun 30. Int J Cardiol. 2018. PMID: 30037626 Free article.

7

Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban.

Tepper PG, Mardekian J, Masseria C, Phatak H, Kamble S, Abdulsattar Y, Petkun W, Lip GYH. Tepper PG, et al. Among authors: masseria c. PLoS One. 2018 Nov 1;13(11):e0205989. doi: 10.1371/journal.pone.0205989. eCollection 2018. PLoS One. 2018. PMID: 30383768 Free PMC article.

8

Response to "Letter to the Editor concerning: 'A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants'".

Cohen AT, Hill NR, Luo X, Masseria C, Abariga SA, Ashaye AO. Cohen AT, et al. Among authors: masseria c. Int J Cardiol. 2020 May 1;306:101. doi: 10.1016/j.ijcard.2019.11.141. Epub 2019 Nov 28. Int J Cardiol. 2020. PMID: 31898985 No abstract available.

9

Corrigendum to "Effectiveness and Safety of Oral Anticoagulants in Adults with Non-valvular Atrial Fibrillation Patients and Concomitant Coronary/Peripheral Artery Disease" American Journal of Medicine 131:09 (2018): 1074-1085.e4.

Lopes RD, Steffel J, Di Fusco M, Keshishian A, Luo X, Li X, Masseria C, Hamilton M, Friend K, Gupta K, Mardekian J, Pan X, Baser O, Jones WS. Lopes RD, et al. Among authors: masseria c. Am J Med. 2020 Oct;133(10):1229-1238. doi: 10.1016/j.amjmed.2020.06.003. Epub 2020 Aug 5. Am J Med. 2020. PMID: 32771226

10

Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease.

Lopes RD, Thomas L, Di Fusco M, Keshishian A, Luo X, Li X, Masseria C, Friend K, Mardekian J, Pan X, Yuce H, Jones WS. Lopes RD, et al. Among authors: masseria c. Am J Cardiol. 2021 Jun 1;148:69-77. doi: 10.1016/j.amjcard.2021.02.021. Epub 2021 Mar 3. Am J Cardiol. 2021. PMID: 33667438 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page